euro adhoc: Curanum AG / Financial Figures/Balance Sheet / CURANUM presents preliminary figures for the 2005 financial year

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc.
The issuer is responsible for the content of this announcement.
--------------------------------------------------------------------------------

07.04.2006

CURANUM AG, Munich, is today publishing preliminary results for the
2005 financial year. Since the auditor, Ernst & Young AG, has been
unable to meet the agreed deadline, the Management Board is
publishing preliminary sales and profit figures, which, according to
statements issued by the auditor, may still be subject to
modification. In addition to this, we shall need to take a
qualification of the auditor's certificate into account.

According to the preliminary figures, CURANUM AG achieved sales
revenues in the 2005 financial year of EUR 188.5 million (previous
year: EUR 183.7 million), which was slightly above the budget for the
total year. In the opinion of the Management Board, the key profit
figures were also ahead of budget. However, one-off accounting
effects brought about by the audit, among other things as a result of
the conversion of the accounting basis to IFRS, depressed the key
figures slightly to below the budgeted level of the operating result.
According to these figures, the CURANUM Group achieved EBITDA profits
(earnings before interest, tax, depreciation and amortization) of EUR
25.8 million (previous year: EUR 22.9 million). Personnel expenses
rose from EUR 92.1 million to EUR 95.5 million. Outlays for rents
rose by only 1.9% to EUR 32.7 million (previous year: EUR 32.1
million). EBIT (earnings before interest and taxes) improved from EUR
16.3 million to EUR 19.6 million. Depreciation amounted to EUR 6.1
million (previous year: EUR 6.6 million).

Due to modified calculation methods used under IFRS, the financial
result fell to -EUR 7.4 million (previous year -EUR 7.2 million). As
a consequence, the pre-tax result in the reporting year was EUR 12.2
million. In the previous year, the CURANUM Group achieved pre-tax
profits of only EUR 9.0 million (+35.6%). Deducting income taxes of
EUR 4.7 million (previous year EUR 4.0 million), Group net profit for
the period rose by 55.1% to EUR 7.5 million (previous year: EUR 4.9
million). This corresponds to earnings per share of EUR 0.25
(previous year: EUR 0.16).

Despite the prepayment for a lease for the seven newly acquired
facilities in North Rhine Westphalia of EUR 10.0 million, cash flow
from current business activity in the reporting year amounted to EUR
12.3 million (previous year: EUR 20.9 million). Cash and cash
equivalents rose from EUR 1.9 million to EUR 2.2 million. The equity
ratio improved from 19.5% to 22.4% as a result of the risen earnings.

Since the operating business has developed as planned during 2005, we
continue to anticipate that we will reach the targets that we
budgeted for the 2006 financial year.

Munich, April 7, 2006

The Management Board

end of announcement euro adhoc 07.04.2006 08:53:59
--------------------------------------------------------------------------------

ots Originaltext: Curanum AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:
Bernd Rothe
Tel.: +49 (0)89 242065-60
E-Mail: bernd.rothe@curanum.de

Branche: Healthcare Providers
ISIN: DE0005240709
WKN: 524070
Index: CDAX, Classic All Share, Prime All Share, SDAX
Börsen: Frankfurter Wertpapierbörse / regulated dealing/prime
standard
Bayerische Börse / regulated dealing
Börse Berlin-Bremen / free trade
Hamburger Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade